BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260506T080000
DTEND;TZID=Europe/Berlin:20260508T170000
DTSTAMP:20260507T183745
CREATED:20250712T062036Z
LAST-MODIFIED:20250712T062110Z
UID:10000212-1778054400-1778259600@oncodaily.com
SUMMARY:The ESMO Breast Cancer 2026
DESCRIPTION:Join the global breast cancer community at ESMO Breast Cancer 2026\, taking place from 6 to 8 May 2026 in Berlin\, Germany\, or online. \nThis international congress will gather top experts\, researchers\, and clinicians to explore the latest advances in breast cancer care\, covering everything from early detection to innovative treatments and survivorship strategies. \nThe event offers a platform to engage with global leaders\, share real-world insights\, and help shape the future of breast cancer treatment. The Scientific Committee is co-chaired by Masakazu Toi\, Sara Tolaney and Nicholas Turner.
URL:https://oncodaily.com/event/esmo-327164
LOCATION:Messe Berlin\, Messedamm 22\, Berlin\, 14055\, Germany
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7076.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260513
DTSTAMP:20260507T183745
CREATED:20260104T001332Z
LAST-MODIFIED:20260104T001344Z
UID:10000547-1778457600-1778630399@oncodaily.com
SUMMARY:ESMO Preceptorship on Hereditary Cancer Genetics 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Hereditary Cancer Genetics 2026 is an intensive educational course scheduled for May 11–12\, 2026\, in Lugano\, Switzerland. \nCo-chaired by Judith Balmaña and Marjolijn Ligtenberg\, this program is designed to provide oncologists with a comprehensive understanding of the molecular basis of genetic susceptibility to cancer. The technical curriculum focuses on the multidisciplinary management of hereditary cancer syndromes\, the identification and diagnosis of germline genetic mutations\, and the implementation of evidence-based prevention strategies. \nThrough a combination of state-of-the-art lectures and interactive clinical case discussions\, the course aims to equip participants with the skills necessary to provide personalized care for patients with hereditary cancer risks. Successful applicants benefit from complimentary registration and accommodation\, and the event is accredited with 9 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodaily.com/event/hereditary-cancer-genetics-436366
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Preceptorship.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260513
DTEND;VALUE=DATE:20260515
DTSTAMP:20260507T183745
CREATED:20260104T001901Z
LAST-MODIFIED:20260104T001917Z
UID:10000548-1778630400-1778803199@oncodaily.com
SUMMARY:ESMO Preceptorship on Head and Neck Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Head and Neck Cancer 2026 is a specialized educational course scheduled for May 13–14\, 2026\, in Lugano\, Switzerland. \nThis program is designed to provide medical and clinical oncologists with a deep understanding of the management of head and neck cancers\, ranging from diagnosis to advanced treatment strategies. The curriculum covers the epidemiology\, etiology\, and molecular biology of nasopharyngeal cancer (NPC) and head and neck squamous cell carcinoma (HNSCC). \nParticipants will explore multidisciplinary management approaches\, including the roles of surgery\, radiation therapy\, and systemic therapy\, with a particular emphasis on the integration of immunotherapy and the management of rare tumors. The course combines plenary lectures with interactive\, case-based sessions to facilitate direct engagement between participants and international experts. Successful applicants receive complimentary registration and accommodation\, and the event is accredited with 11 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodaily.com/event/head-and-neck-cancer-436369
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Preceptorship-on-Head-and-Neck-Cancer.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260515
DTEND;VALUE=DATE:20260517
DTSTAMP:20260507T183745
CREATED:20260104T234351Z
LAST-MODIFIED:20260104T234406Z
UID:10000549-1778803200-1778975999@oncodaily.com
SUMMARY:ESMO Preceptorship on Colorectal Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Colorectal Cancer 2026: Lugano is a specialized educational course scheduled for May 15–16\, 2026\, in Lugano\, Switzerland. \nThis course is designed to provide oncologists – particularly young and general oncologists – with a comprehensive understanding of colorectal cancer management from diagnosis to treatment. The technical program includes plenary lectures by international experts and interactive case-based sessions\, covering best practices in multidisciplinary management for both adjuvant and metastatic settings\, the role of molecular pathology in prognosis\, and the optimal sequencing of systemic therapies. \nSuccessful applicants benefit from complimentary registration and accommodation\, and the event is accredited with 9 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodaily.com/event/colorectal-cancer-2026-436774
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Preceptorship-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260520
DTEND;VALUE=DATE:20260521
DTSTAMP:20260507T183745
CREATED:20260104T234810Z
LAST-MODIFIED:20260104T234817Z
UID:10000550-1779235200-1779321599@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases Webinar: Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases Webinar: Metastatic Breast Cancer 2026 is a virtual scientific webinar\, scheduled for May 20\, 2026\, that focuses on the practical application of ESMO Clinical Practice Guidelines (CPG) in the management of metastatic breast cancer (MBC). \nChaired by Evandro de Azambuja\, the program features a real-world case presentation by Ana Tecic Vuger\, followed by a critical analysis of the current guidelines by Seock-Ah Im. A multidisciplinary panel\, including experts Nadia Harbeck and Giuseppe Curigliano\, will discuss therapeutic sequencing\, decision-making in advanced disease\, and strategies for overcoming implementation challenges in daily clinical practice. The session provides oncology professionals with 1 ESMO-MORA category 1 point. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-436778
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Guidelines-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
END:VCALENDAR